Medical Devices Exports Surge 88% in Six Years Backed by Govt Schemes

The growth has been attributed to several government schemes strengthening the domestic manufacturing ecosystem.

India’s medical devices exports rose by 88% over six financial years, reaching $4,014 million in FY2024-25 from $2,138 million in FY2018-19, according to the Union Ministry of Chemicals and Fertilisers.

The growth has been attributed to several government schemes strengthening the domestic manufacturing ecosystem.

The Production Linked Incentive (PLI) scheme for Promoting Domestic Manufacturing of Medical Devices has played a significant role in this progress. With a total budgetary outlay of Rs 3,420 crore, the scheme spans five years from FY2022-23 to FY2026-27. It has recorded cumulative eligible sales of Rs 10,413.40 crore till March 2025, including export sales worth Rs 5,002 crore.

The scheme provides financial incentives to companies for incremental sales of domestically manufactured medical devices in key segments such as radiotherapy, imaging, anaesthesia, cardio-respiratory, critical care, and implants.

“So far, 21 greenfield projects have been commissioned, and production has started for 54 products, which include high-end medical devices on which the country has been highly import-dependent, such as linear accelerators, MRI and CT machines, mammograms, C-arm X-ray machines, and ultrasound machines,” said Anupriya Patel, Minister of State in the Ministry of Chemicals and Fertilisers, in the Parliament.

Under the Scheme for Promotion of Medical Devices Parks, three parks are in advanced stages of development in Greater Noida (Uttar Pradesh), Ujjain (Madhya Pradesh), and Kanchipuram (Tamil Nadu). The total project cost exceeds Rs 871.11 crore, with the Centre contributing Rs 100 crore each for infrastructure development. These parks aim to improve cost efficiency and competitiveness by enabling shared facilities.

The government also launched the Scheme for Strengthening the Medical Device Industry on November 8, 2024, with a financial outlay of Rs 500 crore. It supports component manufacturing, skill development, clinical studies, and common infrastructure.

Stay tuned for more such updates on Digital Health News